STRATA CRITICAL MEDICAL, INC. Deferred Revenue Recognized
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Deferred Revenue Recognized of $5.21 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2025-08-05
- STRATA CRITICAL MEDICAL, INC. contract with customer, liability, revenue recognized for the quarter ending 2025-03-31 was $3.06M, a 46.06% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. contract with customer, liability, revenue recognized for the quarter ending 2024-03-31 was $2.10M, a 22.00% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. contract with customer, liability, revenue recognized for the quarter ending 2023-03-31 was $2.69M, a 6.99% decline year-over-year.
- STRATA CRITICAL MEDICAL, INC. contract with customer, liability, revenue recognized for the quarter ending 2022-03-31 was $2.89M, a 115.36% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. contract with customer, liability, revenue recognized for fiscal 2024 was $4.87M, a 16.54% decline from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. contract with customer, liability, revenue recognized for fiscal 2023 was $5.84M, a 32.46% increase from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. contract with customer, liability, revenue recognized for fiscal 2022 was $4.41M.
- STRATA CRITICAL MEDICAL, INC. contract with customer, liability, revenue recognized for fiscal 2021 was $2.86M, a 62.94% increase from fiscal 2020.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2025-06-30 | $5.21M 10-Q · filed 2025-08-05 | |||
| 2025-03-31 | $3.06M 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | $4.87M 10-K · filed 2025-03-13 | |||
| 2024-09-30 | $4.47M 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | $3.43M 10-Q · filed 2025-08-05 | |||
| 2024-03-31 | $2.10M 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $5.84M 10-K · filed 2025-03-13 | |||
| 2023-09-30 | $5.21M 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $3.40M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $2.69M 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $4.41M 10-K · filed 2024-03-12 | |||
| 2022-09-30 | $4.16M 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | $3.60M 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | $2.89M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | $1.93M 10-K · filed 2023-03-16 | |||
| 2021-09-30 | $2.99M 10-Q · filed 2022-11-10 | $2.86M 10-K · filed 2023-03-16 | ||
| 2021-06-30 | $2.22M 10-Q · filed 2022-08-09 | |||
| 2021-03-31 | $1.34M 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | $1.18M 8-K · filed 2023-01-10 | |||
| 2020-09-30 | $1.75M 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |